Nobuyuki Aotsuka

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE ‐ STOP219 study

Noriyoshi Iriyama, Naoto Takahashi, K Fujimaki, Takaaki Ono et autres

jp (code pays fourni par la source)

Treatment Outcomes of Adult B-Cell Acute Lymphoblastic Leukemia with Post-Transplant Relapse in the Era of Immunotherapeutic Agents

Hiroaki Shimizu, Yuho Najima, Shinichi Kako, Takayoshi Tachibana et autres

jp (code pays fourni par la source)

Impact of High Serum Lysozyme Activity on Renal Function and Survival Outcomes in Transplant‐Eligible and Ineligible Acute Myeloid Leukemia

Takafumi Tsushima, Kosuke Matsuo, Akihiro Shoji, Chiharu Kimeda et autres

jp (code pays fourni par la source)

Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada et autres

jp (code pays fourni par la source)

A case of KSHV/HHV8-positive large B-cell lymphoma in a background of HIV-negative KSHV/HHV8-positive Multicentric Castleman disease

Takafumi Tsushima, Shiho Konno, Akihiro Shoji, Chiharu Kimeda et autres

jp (code pays fourni par la source)

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukemia in the chronic phase: Result of JALSG CML RE-STOP219 study.

Noriyoshi Iriyama, Naoto Takahashi, Katsumichi Fujimaki, Taka-aki Ono et autres

jp (code pays fourni par la source)

Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

Yasutaka Sadaga, Yuho Najima, Takayoshi Tachibana, Kaito Harada et autres

jp (code pays fourni par la source)

Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation

Takayuki Fujii, Masatoshi Sakurai, Hiroaki Shimizu, Akihiko Izumi et autres

jp, gb (code pays fourni par la source)

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Primary Plasma Cell Leukemia in Japan

Masaya Megaki, Tsutomu Takahashi, Kazuhito Suzuki, Daisuke Minakata et autres

jp (code pays fourni par la source)

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma

Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin‐ichiro Fujiwara et autres

jp (code pays fourni par la source)

Author response for "Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma"

Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin Fujiwara et autres

A case of acute myeloid leukemia with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis successfully treated by cord blood transplantation

Natsumi Yoda, Takafumi Tsushima, Chiharu Kimeda, Kazusuke Tanaka et autres

jp (code pays fourni par la source)